Will AbbVie back off Humira advertising now that it’s announced it will buy Allergan? Maybe. But for now, the Illinois drugmaker is showing no signs of slowing its long-running robust TV ad push for ...
Could Pfizer's Xeljanz become the 2019 challenger to AbbVie’s Humira TV ad crown? The Pfizer anti-inflammatory drug, now boasting three indications, spent $42.2 million on TV ads in December, just ...
The second in a pair of complementary spots for AbbVie’s immunology drug Humira recently hit airwaves, and while it shed some light on the mysterious ad that preceded it, the sequence has elicited a ...
The fall magazines are always fat with ads, and the latest issues of People were no exception. I was happy to spot many DTC ads in one very hefty issue, two of which really stood out—one for Pfizer’s ...
Image above from a recent Humira ad. The Humira wars have begun, as the first branded biosimilar to break Abbvie’s 20-year exclusivity on the top-selling anti-inflammatory drug has launched, cutting ...
WASHINGTON (Reuters) - An advertisement for Abbott Laboratories' Humira minimizes the arthritis drug's risks while suggesting it can treat a wider range of patients than it is approved to treat, the U ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback